What Are the Key Challenges of In Vivo Complexity?
One of the primary challenges is the biocompatibility of nanomaterials. When introduced into the body, nanomaterials can elicit immune responses, potentially leading to inflammation or other adverse effects. Additionally, the biodistribution of nanomaterials—how they spread and localize in different tissues—is often unpredictable and can affect their efficacy and safety.
